Skip navigation Wisconsin State Legislature
This is the preview version of the Wisconsin State Legislature site.
Please see http://docs.legis.wisconsin.gov for the production version.
Up
Chapter CSB 2
ADDITIONS TO SCHEDULES IN SS. 961.14,
961.16, 961.18, 961.20 AND 961.22, STATS.
CSB 2.001   Addition of Methiopropamine to schedule I.
CSB 2.002   Excluding Fenfluramine from schedule IV.
CSB 2.003   Transfer of Flualprazolam and addition of 4 other synthetic Benzodiazepine substances to schedule I.
CSB 2.004   Addition of Zuranolone to Schedule IV.
CSB 2.005   Addition of 9 Fentanyl Related Substances to Schedule I.
CSB 2.006   Adding 5 Synthetic Cannabinoids to Schedule I.
CSB 2.007   Addition of ADB-BUTINACA, alpha-PiHP, and 3-MMC to Schedule I.
CSB 2.008   Addition of 2-Methyl AP-237 to Schedule I.
CSB 2.009   Addition of 2 Synthetic Benzimidazole-Opioids to Schedule I.
Ch. CSB 2 NoteNote: Chapter CSB 2 (except CSB 2 (title)) was renumbered chapter CSB 2 Appendix under s. 13.92 (4) (b) 1., Stats., Register April 2023 No. 808. The appendix is printed at the end of this chapter and contains scheduling actions of the Controlled Substances Board prior to April 3, 2023, which used two-digit numbering ending with s. CSB 2.99. Scheduling actions on or after April 3, 2023, beginning with s. CSB 2.001, are printed below.
CSB 2.001CSB 2.001 Addition of Methiopropamine to schedule I. Section 961.14 (7) (t), Stats., is created to read:
961.14 (7) (t) N-methyl-1-(thiophen-2-yl)propan-2-amine, commonly known as Methiopropamine.
CSB 2.001 HistoryHistory: cr. Affirmative action order under s. 961.11 (4), Stats., Register April 2023 No. 808, eff. 4-3-23.
CSB 2.002CSB 2.002 Excluding Fenfluramine from schedule IV. Section 961.20 (4) (am), Stats., is repealed.
CSB 2.002 HistoryHistory: cr. Affirmative action order under s. 961.11 (4), Stats., Register April 2023 No. 808, eff. 4-17-23; correction made under s. 35.17, Stats., Register April 2023 No. 808.
CSB 2.003CSB 2.003 Transfer of Flualprazolam and addition of 4 other synthetic Benzodiazepine substances to schedule I.
CSB 2.003(1)(1) Section 961.20 (2) (ef), Stats., is repealed.
CSB 2.003(2)(2) Section 961.14 (5) (aa), (ab), (ac), (ad), and (ae), Stats., are created to read:
961.14 (5) (aa) Clonazolam (6-(2-chlorophenyl)-1-methyl-8-nitro-4 H -benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine).
(ab) Diclazepam (7-chloro-5-(2-chlorophenyl)-1-methyl-1,3-dihydro-2 H -benzo[ e][1,4]diazepin-2-one).
(ac) Etizolam (4-(2-chlorophenyl)-2-ethyl-9-methyl-6 H -thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine).
(ad) Flualprazolam (8-chloro-6-(2-fluorophenyl)-1-methyl-4 H -benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine).
(ae) Flubromazolam (8-bromo-6-(2-fluorophenyl)-1-methly-4 H -benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine).
CSB 2.003 HistoryHistory: cr. Affirmative action order under s. 961.11 (4), Stats., Register September 2023 No. 813, eff. 9-25-23; correction in (2) made under s. 35.17, Stats., Register September 2023 No. 813.
CSB 2.004CSB 2.004 Addition of Zuranolone to Schedule IV. Section 961.20 (2) (r), Stats., is created to read:
961.20 (2) (r) Zuranolone.
CSB 2.004 HistoryHistory: cr. Affirmative action order under s. 961.11 (4), Stats., Register February 2024 No. 818, eff. 2-5-24; correction in numbering of CSB 2.004 made under s. 13.92 (4) (b) 1., Stats., Register February 2024 No. 818.
CSB 2.005CSB 2.005 Addition of 9 Fentanyl Related Substances to Schedule I.
CSB 2.005(1)(1) Section 961.14 (2) (nd) 3m., 10m., 11m., 12e., 12m., 12s., 16n., 17g., and 17r., are created to read:
961.14 (2) (nd) 3m. Alpha’-methyl butyryl fentanyl (2-methyl-N-(1-phenethylpiperidin-4-yl)-N-phenylbutanamide);
10m. 2’,5’-dimethoxyfentanyl (N-(1-(2,5-dimethoxyphenethyl)piperidin-4-yl)-N-phenylpropionamide);
11m. 3-furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-3-carboxamide);
12e. Isovaleryl fentanyl (3-methyl-N-(1-phenethylpiperidin-4-yl)-N-phenylbutanamide);
12m. Meta-fluorofentanyl (N-(3-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide);
12s. Meta-fluoroisobutyryl fentanyl (N-(3-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide);
16n. Ortho-fluorofuranyl fentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)furan-2-carboxamide);
17g. Para-methoxyfuranyl fentanyl (N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-yl)furan-2-carboxamide);
17r. Para-methylcyclopropyl fentanyl (N-(4-methylphenyl)-N-(1-phenethylpiperidin-4-yl)cyclopropanecarboxamide);
CSB 2.005 HistoryHistory: cr. Affirmative action order under s. 961.11 (4), Stats., Register February 2024 No. 818, eff. 2-5-24.
CSB 2.006CSB 2.006 Adding 5 Synthetic Cannabinoids to Schedule I.
CSB 2.006(1)(1) Section 961.14 (4) (tb) 54. to 58., Stats., are created to read:
961.14 (4) (tb) 54. Methyl 3,3-dimethyl-2-(1-(pent-4-en-1-yl)-1H-indazole-3-carboxamido)butanoate, commonly known as MDMB-4en-PINACA.
55. Methyl 2-[[1-(4-fluorobutyl)indole-3-carbonyl]amino]-3,3-dimethyl-butanoate, commonly known as 4F-MDMB-BUTICA or 4F-MDMB-BICA.
56. N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(pent-4-en-1-yl)-1H-indazole-3-carboxaminde, commonly known as ADB-4en-PINACA.
57. 5-Pentyl-2-(2-phenylpropan-2-yl)pyrido[4,3-b]indol-1-one, commonly known as CUMYL-PEGACLONE or SGT-151.
58. Ethyl 2-[[1-(5-fluoropentyl)indole-3-carbonyl]amino]-3,3-dimethyl-butanoate, commonly known as 5F-EDMB-PICA or 5F-EDMB-2201.
CSB 2.006 HistoryHistory: cr. Affirmative action order under s. 961.11 (4), Stats., Register February 2024 No. 818, eff. 2-5-24.
CSB 2.007CSB 2.007 Addition of ADB-BUTINACA, alpha-PiHP, and 3-MMC to Schedule I.
CSB 2.007(1)(1) Section 961.14 (4) (tb) 32m. is created to read:
961.14 (4) (tb) 32m. N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-butyl-1H-indazole-3-carboxamide, commonly known as ADB-BUTINACA.
CSB 2.007(2)(2) Section 961.14 (7) (L) 2m. and 36m. are created to read:
961.14 (7) (L) 2m. 3-methylmethcathinone or 2-(methylamino)-1-(3-methylphenyl)propan-1-one, commonly known as 3-MMC.
36m. 4-methyl-1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one, commonly known as alpha-PiHP.
CSB 2.007 HistoryHistory: cr. Affirmative action order under s. 961.11 (4), Stats., Register June 2024 No. 822, eff. 6-17-24; correction in (title) made under s. 13.92 (4) (b) 2., Stats., Register June 2024 No. 822.
CSB 2.008CSB 2.008 Addition of 2-Methyl AP-237 to Schedule I. Section 961.14 (2) (qz), Stats., is created to read:
961.14 (2) (qz) 2-methyl AP-237 (1-(2-methyl-4-(3-phenylprop-2-en-1-yl)piperazin-1-yl)butan-1-one);
CSB 2.008 HistoryHistory: cr. Affirmative action order under s. 961.11 (4), Stats., Register June 2024 No. 822, eff. 5-20-24; correction made under s. 35.17, Stats., Register June 2024 No. 822.
CSB 2.009CSB 2.009 Addition of 2 Synthetic Benzimidazole-Opioids to Schedule I. Section 961.14 (2) (xm) 7e. and 7m., Stats., are created to read:
961.14 (2) (xm) 7e. N-desethyl isotonitazene (N-ethyl-2-(2-(4-isopropoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine).
961.14 (2) (xm) 7m. N-piperidinyl etonitazene also known as etonitazepipne (2-(4-ethoxybenzyl)-5-nitro-1-(2-(piperidin-1-yl)ethyl)-1H-benzimidazole).
Down
Loading...
Loading...
Published under s. 35.93, Stats. Updated on the first day of each month. Entire code is always current. The Register date on each page is the date the chapter was last published.